Correlation Between Immix Biopharma and Virax Biolabs
Can any of the company-specific risk be diversified away by investing in both Immix Biopharma and Virax Biolabs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immix Biopharma and Virax Biolabs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immix Biopharma and Virax Biolabs Group, you can compare the effects of market volatilities on Immix Biopharma and Virax Biolabs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immix Biopharma with a short position of Virax Biolabs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immix Biopharma and Virax Biolabs.
Diversification Opportunities for Immix Biopharma and Virax Biolabs
0.89 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Immix and Virax is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding Immix Biopharma and Virax Biolabs Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virax Biolabs Group and Immix Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immix Biopharma are associated (or correlated) with Virax Biolabs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virax Biolabs Group has no effect on the direction of Immix Biopharma i.e., Immix Biopharma and Virax Biolabs go up and down completely randomly.
Pair Corralation between Immix Biopharma and Virax Biolabs
Given the investment horizon of 90 days Immix Biopharma is expected to generate 0.59 times more return on investment than Virax Biolabs. However, Immix Biopharma is 1.68 times less risky than Virax Biolabs. It trades about 0.05 of its potential returns per unit of risk. Virax Biolabs Group is currently generating about 0.01 per unit of risk. If you would invest 105.00 in Immix Biopharma on August 28, 2024 and sell it today you would earn a total of 67.00 from holding Immix Biopharma or generate 63.81% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Immix Biopharma vs. Virax Biolabs Group
Performance |
| Timeline |
| Immix Biopharma |
| Virax Biolabs Group |
Immix Biopharma and Virax Biolabs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Immix Biopharma and Virax Biolabs
The main advantage of trading using opposite Immix Biopharma and Virax Biolabs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immix Biopharma position performs unexpectedly, Virax Biolabs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virax Biolabs will offset losses from the drop in Virax Biolabs' long position.| Immix Biopharma vs. ZyVersa Therapeutics | Immix Biopharma vs. Hepion Pharmaceuticals | Immix Biopharma vs. Cns Pharmaceuticals | Immix Biopharma vs. Sonnet Biotherapeutics Holdings |
| Virax Biolabs vs. Eliem Therapeutics | Virax Biolabs vs. HCW Biologics | Virax Biolabs vs. Scpharmaceuticals | Virax Biolabs vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |